In patients with chronic HCV, hepatic expression of AdipoR1, and AdipoR2 appeared to be differentially regulated in the setting of hepatic insulin resistance, as measured by hepatic PEPCK expression, and in response to serum adiponectin (12). Here, ADIPOQ is linked to Insulin resistance.